Botanical species · safety record

Elaeagnus angustifolia

The EFSA Compendium of Botanicals holds 6 constituent measurements for Elaeagnus angustifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Elaeagnus angustifolia L.

6Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Harmane alkaloids2
  • Coumarins1
  • Saponins1
  • Tannins1
  • Tetrahydroharman1

Plant parts

  • Fruit unspecified2
  • Bark1
  • Leaves1
  • Live plants1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Harmane alkaloidsBarkSolvent extraction0.32 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
TetrahydroharmanStem / stalkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CoumarinsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier
Harmane alkaloidsLive plantsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
SaponinsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Abizov, E. A., Tolkachev, O. N., Mal'tsev, S. D., Abizova, E. V. COMPOSITION OF BIOLOGICALLY ACTIVE SUBSTANCES ISOLATED FROM THE FRUITS OF RUSSIAN OLIVE (Elaeagnus angustifolia) INTRODUCED IN THE EUROPEAN PART OF RUSSIA. Khimiko-Farmatsevticheskii Zhurnal, 2008, vol. 42, no. 12, p. 23-25.
  2. Tolkachev, O.N., Abizov, E.A., Abizova, E.V., Mal'Tsev, S.D. Phytochemical study of the bark of some plants of the Elaeagnaceae family as a natural source of beta-carboline indole alkaloids. Pharmaceutical Chemistry Journal, 2008, vol. 42, no. 11, p. 630-632. DOI
  3. Gill, Stanislaw., Raszeja, Wanda. Chromatographic analysis of harman derivatives in some plant raw materials. Gdansk. tow. nauk., rozpr. wydz. 3, 1971, p. 137-143.
  4. McFarlane, I.J., Slaytor, M. The role of N-acetyl amines in tetrahydro-beta-carboline and tetrahydroisoquinoline biosynthesis. Phytochemistry, 1972, vol. 11, no. 1, p. 229-234. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue